Patients with MDD have also been reported to show elevated levels of LBP and I-FABP, alongside increased circulating inflammatory cytokines, including TNF-α and IL-1β, indicating a concurrent disruption of intestinal barrier integrity and systemic inflammation. This evidence concerns the gene LBP and major depressive disorder.